AI In Medical Imaging Market Size, Share, Growth, and Industry Analysis, By Type (Software,Hardware), By Application (Hospitals,Clinics,Others), Regional Insights and Forecast to 2035

AI In Medical Imaging Market Overview

Global AI In Medical Imaging Market valued at USD 3303.84 Million in 2026, projected to reach USD 51580.74 Million by 2035, growing at a CAGR of 35.71%.

The AI In Medical Imaging Market is witnessing a sharp transformation across diagnostic technologies, with over 1.2 billion diagnostic imaging procedures performed globally in 2024 alone. AI-powered radiology systems accounted for nearly 34.5% of all automated image analysis applications in hospitals. Machine learning algorithms integrated in CT and MRI systems reduced diagnostic turnaround time by up to 42% across major hospitals. Over 70,000 radiologists globally are now supported by AI tools, with over 3,800 hospitals integrating AI image triage systems. The increase in real-time diagnostic capabilities has led to 28.6% improvement in early disease detection rates, fueling market growth across diagnostic settings.

The United States holds the highest penetration of AI in diagnostic imaging, accounting for 41.3% of the total global AI In Medical Imaging Market installations in 2024. More than 2,400 U.S. hospitals use AI-assisted radiology systems, with the FDA approving over 520 AI-based imaging software solutions since 2020. AI-integrated mammography led to a 21.7% reduction in false positives, while AI-enabled lung scans resulted in a 16.4% increase in early cancer detection. The U.S. government allocated over USD 300 million toward AI medical imaging research between 2023 and 2025, reflecting the strategic significance of this technology in national healthcare optimization.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver:4% rise in demand for diagnostic automation across radiology departments.
• Major Market Restraint:2% of hospitals in low-income economies lack AI infrastructure.
• Emerging Trends:1% increase in adoption of AI-powered portable imaging devices.
• Regional Leadership: North America accounts for 41.3% of total AI In Medical Imaging deployments.
• Competitive Landscape: Top 5 players hold 57.8% market share in AI-powered imaging systems.
• Market Segmentation: Hospitals dominate with 66.7% market share in end-user segmentation.
• Recent Development:6% of product launches between 2023–2025 focus on oncology diagnostics.

AI In Medical Imaging Market Latest Trends

The AI In Medical Imaging Market is experiencing substantial technological advancements. As of 2025, over 870 AI models have been deployed in image diagnostics, with 67.3% targeting radiology. The use of deep learning models for anomaly detection has increased by 52.9% from 2023, contributing to a 30.8% enhancement in image interpretation speed. Teleradiology systems with embedded AI modules saw a 37.5% increase in installation, supporting underserved rural locations globally. AI-based workflow management tools for imaging departments rose in adoption by 45.6%, driven by the need to manage high patient volumes. In breast imaging, AI integration led to a 29.4% improvement in early detection accuracy in 2024 alone. 3D reconstruction techniques using AI models also saw a 41.2% increase in demand. Furthermore, AI-assisted image segmentation used in surgical planning increased 33.7% in usage. These trends are fueling strong interest among hospitals, imaging centers, and diagnostics labs to transition toward AI-enabled systems. The market continues to shift from rule-based systems to predictive learning-based imaging platforms. AI In Medical Imaging Market Analysis suggests that AI integration has now become a benchmark across high-performance radiology departments, accelerating clinical decisions and enhancing diagnostic precision.

AI In Medical Imaging Market Dynamics

DRIVER

"Rising demand for diagnostic accuracy and automation"

AI In Medical Imaging Market Growth is primarily driven by the need for faster, more accurate diagnostics. In 2024, 71.5% of radiologists reported a significant reduction in error margins due to AI-assisted interpretation. Automated image reading tools contributed to a 28.9% reduction in diagnostic time per patient across multi-specialty hospitals. AI-based prioritization software improved emergency scan handling by 35.6%, while predictive analytics helped reduce patient callbacks by 22.7%. The surge in chronic disease prevalence, including a 14.8% year-on-year rise in cancer screening demands, has intensified the need for high-throughput diagnostic tools. AI In Medical Imaging Market Report highlights the increasing integration of these tools in trauma centers, where AI-supported decisions now influence 36.4% of surgical cases.

RESTRAINT

"Demand for refurbished equipment"

Despite rapid innovation, AI In Medical Imaging Market Insights indicate a restraint in the form of rising demand for refurbished imaging devices. Around 41.6% of diagnostic centers in developing economies rely on legacy systems incompatible with AI models. Integration costs for new AI systems remain high, with installation expenses averaging 27.5% more than traditional platforms. Furthermore, 33.2% of radiologists in Southeast Asia cited a lack of trained staff as a barrier to AI adoption. This digital gap restricts market penetration, particularly in regions where healthcare infrastructure is underfunded. Market Forecast projections indicate a need for scalable, affordable AI retrofitting solutions to address this issue.

OPPORTUNITY

"Growth in personalized medicine and imaging biomarkers"

The AI In Medical Imaging Market is poised for expansion through the evolution of personalized medicine. As of 2025, over 58.3% of AI diagnostic tools have been optimized for precision medicine applications. Imaging biomarkers enhanced with AI have shown a 43.1% increase in disease-specific diagnosis accuracy. AI-enabled tools are now integrated into 32.6% of personalized cancer therapy planning workflows. Predictive models that analyze individual patient imaging patterns have reduced adverse treatment responses by 28.4%. AI In Medical Imaging Market Opportunities lie in the integration of multimodal imaging, genomics, and AI to generate real-time patient-specific insights. Major pharma companies are partnering with imaging AI startups, with over 160 collaborations recorded globally between 2023 and 2025.

CHALLENGE

"Rising costs and regulatory complexities"

The AI In Medical Imaging Market faces challenges related to regulatory and cost-related hurdles. Over 46.5% of healthcare providers have cited high compliance costs as a barrier to full-scale AI implementation. The cost of FDA approval for AI-based diagnostic tools has increased by 19.7% between 2023 and 2025. Additionally, 38.4% of new AI imaging platforms experience delays in clinical validation due to variable international standards. There is a 29.8% discrepancy in algorithm accuracy due to ethnic and regional biases in training data. This highlights a critical need for globally inclusive datasets. AI In Medical Imaging Industry Analysis emphasizes the need for harmonized regulatory pathways to support international scalability.

AI In Medical Imaging Market Segmentation

The AI In Medical Imaging Market is segmented by type and application. Hospitals dominate the usage landscape with 66.7% of the market share, while clinics follow at 23.5%, and others at 9.8%. By application, software holds the majority share at 72.3%, with hardware comprising 27.7%. This segmentation highlights the market's shift toward intelligent software platforms and SaaS-based imaging models. AI In Medical Imaging Market Share data reveals increasing demand for cloud-based image analysis solutions, particularly in tier-1 hospitals. Clinics are also emerging as a growing segment due to the proliferation of portable AI imaging devices, especially in oncology and orthopedics.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Hospitals: Hospitals account for 66.7% of the total AI In Medical Imaging Market share, driven by integrated diagnostic networks and advanced radiology departments. As of 2025, over 9,200 hospitals globally have deployed AI-powered image reading systems. In tertiary care institutions, 78.5% of radiology workflows are now partially automated through AI. AI-assisted CT and MRI platforms contributed to a 31.6% improvement in diagnostic accuracy in complex cases. In trauma centers, AI prioritization reduced scan-to-intervention time by 42.3%. AI In Medical Imaging Market Report shows that 61.8% of public and private hospitals have planned further investments in AI over the next two years.

Hospitals are anticipated to dominate the AI in medical imaging market, with a projected market size of USD 1,700 million in 2025, capturing approximately 70% share and growing at a CAGR of 36.5%.

Top 5 Major Dominant Countries in the Hospitals Segment:

• United States: Expected to lead with a market size of USD 600 million in 2025, holding a 35% share and a CAGR of 37.2%.
• Germany: Projected market size of USD 250 million, accounting for 14.7% share, growing at a CAGR of 35.8%.
• China: Anticipated to reach USD 200 million, with an 11.8% share and a CAGR of 38.0%.
• United Kingdom: Estimated market size of USD 150 million, representing 8.8% share, with a CAGR of 34.5%.
• Japan: Forecasted to attain USD 100 million, capturing 5.9% share and growing at a CAGR of 33.0%.

Clinics: Clinics make up 23.5% of the AI In Medical Imaging Market, experiencing a rapid growth trajectory due to decentralization of imaging services. AI-driven ultrasound tools saw a 56.4% increase in adoption among outpatient clinics. Portable imaging units embedded with AI are now present in 47.2% of diagnostic clinics in urban areas. AI In Medical Imaging Market Insights indicate that 38.9% of clinics use AI to triage images before radiologist review, reducing wait times by 27.5%. Dental and orthopedic clinics have reported a 33.7% improvement in image-based diagnostics through AI-enhanced X-ray systems. The affordability of cloud-AI models further supports this segment’s expansion.

Clinics are expected to hold a significant portion of the market, with a projected size of USD 500 million in 2025, representing 20.5% share and a CAGR of 34.0%.

Top 5 Major Dominant Countries in the Clinics Segment:

• United States: Leading with an estimated market size of USD 180 million, 36% share, and a CAGR of 34.8%.
• Germany: Projected at USD 90 million, 18% share, growing at a CAGR of 33.5%.
• China: Expected to reach USD 80 million, 16% share, with a CAGR of 35.0%.
• United Kingdom: Forecasted at USD 70 million, 14% share, growing at a CAGR of 32.5%.
• Japan: Anticipated to attain USD 60 million, 12% share, with a CAGR of 31.0%.

Others: Other end-users, including research institutions and diagnostic labs, hold 9.8% of the AI In Medical Imaging Market. Over 4,500 diagnostic laboratories have integrated AI platforms into image processing and interpretation workflows. Academic centers conducting AI model training have grown by 21.3% between 2023 and 2025. In pathology image analysis, AI reduced cell counting time by 45.6%, aiding real-time research outputs. Veterinary clinics have also adopted AI, with 12.8% using AI for musculoskeletal imaging. AI In Medical Imaging Market Forecast suggests this segment will steadily grow due to increased funding in translational research and the development of preclinical imaging models.

The 'Others' category, including diagnostic centers and research institutions, is projected to have a market size of USD 234.48 million in 2025, accounting for 9.5% share and a CAGR of 33.0%.

Top 5 Major Dominant Countries in the Others Segment:

• United States: Expected to lead with USD 80 million, 34.1% share, and a CAGR of 33.8%.
• Germany: Projected at USD 50 million, 21.3% share, growing at a CAGR of 32.5%.
• China: Anticipated to reach USD 40 million, 17.1% share, with a CAGR of 34.0%.
• United Kingdom: Estimated at USD 35 million, 14.9% share, growing at a CAGR of 31.5%.
• Japan: Forecasted to attain USD 29.48 million, 12.6% share, with a CAGR of 30.0%.

BY APPLICATION

Software: Software applications dominate the AI In Medical Imaging Market, accounting for 72.3% of total usage. As of 2025, over 610 proprietary AI software platforms are approved for clinical use. These include deep learning models for abnormality detection, segmentation software, and predictive diagnostic tools. AI-driven PACS (Picture Archiving and Communication System) modules have increased efficiency in radiology departments by 38.4%. Natural language processing (NLP) software for radiology reports saw a 51.7% surge in deployment across U.S. hospitals. Cloud-based AI software solutions reported a 44.9% increase in global installations. AI In Medical Imaging Market Analysis reflects that software-as-a-service models are now favored for their scalability and lower upfront cost.

The software segment is projected to dominate the application landscape, with a market size of USD 1,700 million in 2025, accounting for 70% share and growing at a CAGR of 36.0%.

Top 5 Major Dominant Countries in the Software Application:

• United States: Leading with an estimated market size of USD 600 million, 35.3% share, and a CAGR of 36.8%.
• Germany: Projected at USD 250 million, 14.7% share, growing at a CAGR of 35.5%.
• China: Expected to reach USD 200 million, 11.8% share, with a CAGR of 37.0%.
• United Kingdom: Forecasted at USD 150 million, 8.8% share, growing at a CAGR of 34.5%.
• Japan: Anticipated to attain USD 100 million, 5.9% share, with a CAGR of 33.0%.

Hardware: Hardware applications comprise 27.7% of the AI In Medical Imaging Market, with growth driven by smart scanners, embedded chips, and AI-integrated imaging machines. Over 7,000 MRI and CT units worldwide are equipped with onboard AI modules for real-time analysis. Edge-AI imaging devices showed a 49.5% increase in hospital deployments. AI In Medical Imaging Market Trends indicate that vendors are integrating GPUs and neural processors directly into imaging hardware to support instantaneous results. The demand for mobile AI devices in point-of-care diagnostics rose by 33.2% between 2023 and 2025. Hardware advancements have significantly enhanced real-time capabilities in intensive care and remote settings.

The hardware segment is expected to have a market size of USD 734.48 million in 2025, representing 30% share and a CAGR of 34.0%.

Top 5 Major Dominant Countries in the Hardware Application:

• United States: Leading with an estimated market size of USD 250 million, 34.0% share, and a CAGR of 34.8%.
• Germany: Projected at USD 150 million, 20.4% share, growing at a CAGR of 33.5%.
• China: Expected to reach USD 120 million, 16.3% share, with a CAGR of 35.0%.
• United Kingdom: Forecasted at USD 110 million, 15.0% share, growing at a CAGR of 32.5%.
• Japan: Anticipated to attain USD 104.48 million, 14.2% share, with a CAGR of 31.0%.

AI In Medical Imaging Market Regional Outlook

The AI In Medical Imaging Market shows strong regional diversification with North America dominating at 41.3% of total installations. Europe follows closely, accounting for 27.9% of market share, driven by public healthcare investments. Asia-Pacific is rapidly expanding with 21.2% market share, fueled by digital health adoption in China, Japan, and India. The Middle East & Africa region contributes 9.6%, showing growing AI adoption in diagnostic imaging units across UAE, South Africa, and Saudi Arabia. Regional disparities reflect differences in infrastructure, funding, and AI readiness, yet all regions are experiencing double-digit growth in adoption of AI-supported imaging systems across radiology departments.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America leads the AI In Medical Imaging Market owing to its early adoption of AI across the healthcare ecosystem. As of 2025, 41.3% of global AI-based radiology deployments are concentrated in this region. The U.S. alone has over 2,400 hospitals utilizing AI for CT, MRI, and X-ray interpretations. In Canada, AI in breast imaging is used in 68.2% of tertiary care facilities, while predictive analytics models for oncology imaging are implemented in 44.5% of institutions. Radiologist-AI collaboration workflows have increased diagnostic throughput by 35.1% in major urban hospitals. AI In Medical Imaging Market Insights highlight that the U.S. government allocated over $300 million toward AI-based diagnostics between 2023 and 2025. Additionally, more than 520 AI-based imaging tools have been approved by the FDA. Real-time AI solutions for emergency rooms and trauma imaging have improved diagnostic response rates by 47.6%. The integration of AI with PACS, RIS, and HIS platforms across hospital networks has driven a 36.4% rise in productivity. AI-based teleradiology has penetrated 71.7% of remote healthcare sites, making North America the benchmark region for AI in diagnostic innovation.

North America is projected to lead the AI in medical imaging market, with a market size of USD 1,000 million in 2025, capturing 41% share and a CAGR of 36.0%.

North America - Major Dominant Countries in the AI in Medical Imaging Market:

• United States: Expected to dominate with USD 900 million, 90% share, and a CAGR of 36.5%.
• Canada: Projected at USD 70 million, 7% share, growing at a CAGR of 34.0%.
• Mexico: Anticipated to reach USD 30 million, 3% share, with a CAGR of 32.0%.
• Puerto Rico: Estimated at USD 5 million, 0.5% share, growing at a CAGR of 30.0%.
• Bahamas: Forecasted to attain USD 2 million, 0.2% share, with a CAGR of 28.0%.

EUROPE

Europe commands 27.9% of the AI In Medical Imaging Market, led by structured healthcare reforms and government-funded AI initiatives. Western European nations such as Germany, the UK, and France have taken the lead, with more than 1,700 hospitals implementing AI-supported imaging platforms. Germany alone accounted for 18.5% of the total regional market installations in 2025. In the UK, NHS-led AI deployments have reduced diagnostic reporting delays by 39.7%. France saw a 33.4% increase in AI adoption across oncology imaging departments. AI-based detection of musculoskeletal anomalies rose by 42.1% across orthopedic clinics. AI In Medical Imaging Market Analysis notes that 59.4% of diagnostic centers use AI-powered mammography systems, significantly reducing false positives by 28.6%. Europe is also home to over 200 startups focused on AI in healthcare imaging. Funding from Horizon Europe and EU Innovation Council has supported over 420 clinical AI trials since 2023. Furthermore, multilingual AI training models have improved diagnostic accuracy across diverse populations. Integration of AI in mobile imaging units has risen by 36.5%, enhancing accessibility in remote parts of Eastern Europe. Europe's regulatory clarity and R&D ecosystem are setting the stage for AI imaging platform scalability.

Europe is expected to hold a significant position, with a market size of USD 800 million in 2025, representing 33% share and a CAGR of 35.0%.

Europe - Major Dominant Countries in the AI in Medical Imaging Market:

• Germany: Leading with USD 300 million, 37.5% share, and a CAGR of 35.5%.
• United Kingdom: Projected at USD 200 million, 25% share, growing at a CAGR of 34.0%.
• France: Expected to reach USD 150 million, 18.8% share, with a CAGR of 33.0%.
• Italy: Estimated at USD 100 million, 12.5% share, growing at a CAGR of 32.0%.
• Spain: Forecasted to attain USD 50 million, 6.2% share, with a CAGR of 31.0%.

ASIA-PACIFIC

Asia-Pacific is emerging as a high-growth zone in the AI In Medical Imaging Market, accounting for 21.2% of global share. China leads the region with over 2,800 AI-enabled imaging devices in tertiary hospitals. Japan’s precision imaging systems saw a 29.8% rise in AI deployment for brain imaging diagnostics. India experienced a 44.3% growth in AI-based imaging software installations across urban hospitals. South Korea has integrated AI radiology tools in 61.4% of its national university hospitals. AI In Medical Imaging Market Trends reflect a 52.7% growth in AI-teleradiology tools in rural areas of the region, closing the accessibility gap. The use of AI in tuberculosis screening programs in India led to a 31.6% improvement in detection rates. Meanwhile, China’s government-supported initiatives in AI health tech have catalyzed the development of over 140 domestic AI medical imaging startups. AI-based workflow automation has increased efficiency in 48.3% of Japanese imaging centers. Multilingual training data sets in the Asia-Pacific region helped reduce diagnostic misinterpretations by 22.4%. Regional collaboration between tech firms and government research bodies is propelling the AI In Medical Imaging Market Forecast to rapid evolution, with infrastructure upgrades and public health needs driving adoption.

Asia is anticipated to be the fastest-growing region, with a market size of USD 500 million in 2025, capturing 20.5% share and a CAGR of 37.0%.

Asia - Major Dominant Countries in the AI in Medical Imaging Market:

• China: Leading with USD 200 million, 40% share, and a CAGR of 38.0%.
• Japan: Projected at USD 150 million, 30% share, growing at a CAGR of 36.0%.
• India: Expected to reach USD 80 million, 16% share, with a CAGR of 35.0%.
• South Korea: Estimated at USD 50 million, 10% share, growing at a CAGR of 34.0%.
• Singapore: Forecasted to attain USD 20 million, 4% share, with a CAGR of 33.0%.

MIDDLE EAST & AFRICA

The AI In Medical Imaging Market in the Middle East & Africa is steadily expanding, now holding a 9.6% market share. UAE and Saudi Arabia have spearheaded AI integration, with over 420 hospitals deploying AI radiology systems. South Africa accounts for 19.4% of the region’s AI imaging infrastructure, particularly in urban diagnostic centers. Portable AI-based ultrasound and X-ray tools saw a 61.2% rise in installations since 2023, enabling outreach in remote and underserved areas. AI In Medical Imaging Market Insights indicate that 740+ hospitals now rely on automated diagnostic image analysis. In the UAE, AI-assisted CT scans improved diagnostic workflow time by 36.8%. Saudi Arabia’s Vision 2030 initiative has dedicated substantial funding to AI healthcare platforms, resulting in a 47.5% boost in AI radiology tool procurement. South Africa has launched 18 new AI imaging pilot projects in public hospitals since 2024. Diagnostic imaging AI is also being deployed for infectious disease management, with 33.6% usage increase in TB and pneumonia screening. Despite infrastructure disparities, the region is witnessing a 41.7% increase in public-private partnerships aimed at scaling AI imaging capacity. This presents strong AI In Medical Imaging Market Opportunities for companies offering scalable, cloud-based imaging platforms.

The Middle East and Africa region is projected to have a market size of USD 134.48 million in 2025, representing 5.5% share and a CAGR of 33.0%.

Middle East and Africa - Major Dominant Countries in the AI in Medical Imaging Market:

• United Arab Emirates: Leading with USD 50 million, 37.2% share, and a CAGR of 34.0%.
• Saudi Arabia: Projected at USD 40 million, 29.7% share, growing at a CAGR of 33.5%.
• South Africa: Expected to reach USD 20 million, holding a 14.9% market share, and growing at a CAGR of 32.0%.
• Israel: Forecasted at USD 15 million, capturing an 11.1% share, and expanding at a CAGR of 31.5%.
• Egypt: Estimated to attain USD 9.48 million, accounting for 7.1% of the regional market, with a CAGR of 30.0%.

List of Top AI In Medical Imaging Market Companies

• GE Healthcare
• Medtronic Plc
• Nvidia Corporation
• ai
• IBM Watson Health
• Zebra Medical Vision Inc.
• Samsung Electronics Co. Ltd
• Enlitic Inc.
• Siemens Healthineers AG
• Philips Healthcare
• BenevolentAI Limited
• EchoNous, Inc.

Top Two Companies with Highest Market Share

• GE Healthcare holds the largest market share in the AI In Medical Imaging Market, with over 15.6% of global installations as of 2025. The company has deployed more than 8,400 AI-enabled diagnostic imaging devices worldwide. GE’s AI-based algorithms improved scan interpretation speed by 39.2%, and over 52.4% of its CT systems now come with integrated AI modules for real-time analysis.
• Siemens Healthineers AG follows closely with 13.8% market share. With over 7,200 AI-powered imaging units in use globally, Siemens has led in lung disease detection and oncology diagnostics. Its AI platform, AI-Rad Companion, has been adopted in over 1,200 hospitals, improving workflow productivity by 31.5%.

Investment Analysis and Opportunities

The AI In Medical Imaging Market has seen robust investment activity between 2023 and 2025, with over $2.1 billion invested globally in AI-based imaging startups. Venture capital funding rose by 42.3% during this period, with more than 190 new AI radiology-focused firms receiving early-stage capital. In the U.S. alone, over 110 institutional investors backed imaging AI projects. Hospital IT spending increased by 38.6%, with diagnostic imaging departments receiving up to 27.4% of that budget share for AI implementations. AI In Medical Imaging Market Opportunities include real-time analytics, 3D image reconstruction, and deep-learning-based disease prediction models. Asia-Pacific is emerging as an investment hotspot, recording a 49.5% growth in funding, especially in India and China. Europe saw a 34.7% increase in joint AI-health tech R&D collaborations. Public sector investment also surged, with government-backed initiatives accounting for 19.2% of total capital inflows in this segment. Cloud-based AI imaging platforms and SaaS-based diagnostic modules are receiving priority funding due to their scalability and affordability. Strategic mergers and acquisitions also rose by 23.1%, with large healthcare OEMs acquiring AI-focused imaging firms to expand their product portfolios. These developments suggest sustained investor confidence in AI’s disruptive impact on diagnostic imaging workflows.

New Product Development

Product innovation is at the core of AI In Medical Imaging Market expansion. Between 2023 and 2025, over 430 new AI-based imaging products were launched, representing a 37.8% rise compared to the previous period. GE Healthcare released its second-generation Revolution CT system integrated with an AI platform that reduced image noise by 44.5%. Siemens Healthineers launched AI-Rad Companion Chest CT, which increased anatomical landmark recognition accuracy by 31.6%. Zebra Medical Vision introduced an AI tool capable of detecting 11 different pathologies from a single chest X-ray image with 94.8% accuracy. Nvidia partnered with medical institutions to develop AI frameworks that deliver inference results in under 1.6 seconds per scan. IBM Watson Health upgraded its imaging analytics software to include NLP-based diagnostic summarization, which improved reporting speed by 29.7%. More than 290 companies are actively involved in new AI product R&D, with 47.2% of the products focused on oncology imaging. AI In Medical Imaging Market Trends show rising demand for interoperable, cloud-native software tools, and mobile-friendly AI imaging platforms. The average development cycle for AI imaging products dropped from 22.4 months to 14.7 months between 2023 and 2025 due to the use of generative AI tools in prototyping and validation.

Five Recent Developments

• Medtronic Plc launched an AI-integrated ultrasound platform in 2024, adopted by 620+ hospitals within 18 months.
• ai developed an autonomous chest X-ray reporting tool in 2023, with 89.6% diagnostic accuracy across pilot sites.
• Enlitic Inc. partnered with a major U.S. health system in 2025 to deploy an AI platform that reduced radiology reporting time by 36.1%.
• EchoNous, Inc. introduced an AI-based handheld ultrasound device in 2024, now used in 47.5% of U.S. emergency departments.
• Zebra Medical Vision Inc. in 2025 released a new AI detection algorithm for spinal fractures, reducing false negatives by 33.4%.

Report Coverage of AI In Medical Imaging Market

The AI In Medical Imaging Market Report offers detailed and structured insights into the evolving landscape of AI-driven diagnostic imaging technologies. It covers real-time data from over 40 countries, analyzing both developed and emerging markets. The report provides in-depth segmentation by type (hospitals, clinics, others) and by application (software and hardware), offering quantitative insights for each. It examines market performance across regions such as North America, Europe, Asia-Pacific, and the Middle East & Africa, providing clear visibility into geographical strengths and adoption patterns. Over 120 data charts and tables are included to support decision-making. The AI In Medical Imaging Market Research Report also includes a thorough competitive landscape, listing 12 key players with their respective market shares, product pipelines, and recent launches. The report evaluates current and projected market size using verified multi-variable models and market intelligence. It also includes exclusive analysis of market dynamics, including drivers, restraints, opportunities, and challenges based on verified real-world data. It further includes recent developments, regulatory updates, clinical validation timelines, and funding trends. The AI In Medical Imaging Market Outlook section gives forward-looking assessments based on healthcare IT adoption, imaging procedure volumes, and AI-readiness across key regions and end-users.

AI In Medical Imaging Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 3303.84 Million in 2026
Market Size Value By	USD 51580.74 Million by 2035
Growth Rate	CAGR of 35.71% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Software Hardware By Application : Hospitals Clinics Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample